1. Range of mean changes from baseline in A1C in clinical studies of 24–52 weeks’ duration reported in prescribing information for five GLP-1 receptor agonists (13–18).
Range of mean changes from baseline in A1C in clinical studies of 24–52 weeks’ duration reported in prescribing information for five GLP-1 receptor agonists (13–18). Each square represents the finding from one study. Drugs were tested as monotherapy or in combination with oral medications except as noted. *Finding reported as comparator in clinical study in another drug’s prescribing information. †Finding for drug in combination with insulin. QD, once daily.
Deborah Hinnen Diabetes Spectr 2017;30:
©2017 by American Diabetes Association